[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MacDonald et al., 1985 - Google Patents

Studies of bile lipids and bile acids of wild North American black bears in Nova Scotia, showing a high content of ursodeoxycholic acid

MacDonald et al., 1985

Document ID
16946572592180055109
Author
MacDonald A
Williams C
Publication year
Publication venue
Journal of Surgical Research

External Links

Snippet

Does ursodeoxycholic acid (UDC) production protect hibernating species of Ursidae against gallstone disease? Five wild bears (Ursis Americana) were studied. Older bears had more UDC than younger ones, suggesing UDC production is an acquired phenomena. Bile salt …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo

Similar Documents

Publication Publication Date Title
Leveille et al. Mechanism of the cholesterol-depressing effect of pectin in the cholesterol-fed rat
Michnovicz et al. Altered estrogen metabolism and excretion in humans following consumption of indole‐3‐carbinol
Platel et al. Stimulatory influence of select spices on bile secretion in rats
Wogan et al. Excretion and tissue distribution of radioactivity from aflatoxin B1-14C in rats
Dalvi et al. Experimental induction of chronic aflatoxicosis in chickens by purified aflatoxin B1 and its reversal by activated charcoal, phenobarbital, and reduced glutathione
Cravedi et al. Digestibility of chloramphenicol, oxolinic acid and oxytetracycline in rainbow trout and influence of these antibiotics on lipid digestibility
Boylan et al. Cholestyramine: use as a new therapeutic approach for chlordecone (kepone) poisoning
Feron et al. Lifespan oral toxicity study of vinyl chloride in rats
JPH04352718A (en) Remedy for enhancing capacity of storing glycogen in animal liver
Balk et al. The uptake and distribution of [3H] benzo [a] pyrene in the Northern pike (Esox lucius). Examination by whole-body autoradiography and scintillation counting
Spatz et al. Cycasin excretion in conventional and germfree rats
Malinow et al. Alfalfa seeds: effects on cholesterol metabolism
Schwartz et al. Inability of red beet betalain pigments to initiate or promote hepatocarcinogenesis
Tabata et al. Mechanism of induction of mucosal ornithine decarboxylase by food
Theodorou et al. Absorptive and motor components of the antidiarrhoeal action of loperamide: an in vivo study in pigs.
Reid Pharmacokinetics of propofol as an induction agent in geriatric dogs
MacDonald et al. Studies of bile lipids and bile acids of wild North American black bears in Nova Scotia, showing a high content of ursodeoxycholic acid
Hajjar et al. Effect of chronic ethanol consumption on leucine absorption in the rat small intestine
KR100786122B1 (en) Composition effective for prevention and treatment of obesity which contains crude drug extract
Riley et al. Delayed‐release mesalazine (5‐aminosalicylic acid): coat dissolution and excretion in ileostomy subjects.
Culik Fluoride turnover in adélie penguins (Pygoscelis adeliae) and other brid species
WO2000071111A1 (en) Stimulating transport of glucose into animal tissue by the administration of pinitol
Sims et al. The microbial metabolism of tryptophan in rats fed a diet containing 7.5% saccharin in a two-generation protocol
OKUDA et al. The thyroid and absorption of vitamin B12 in rats
Tanaka et al. A new method to measure gastric emptying in conscious dogs: a validity study and effects of EM523 and L-NNA